Optimization of the protocols for double vaccination against marek's disease by using commercially available vaccines: Evaluation of protection, vaccine replication, and activation of T cells

Avian Diseases

Volumn 56, Issue 2, 2012, Pages 295-305

  Gimeno, Isabel M ^a   Cortes, Aneg L ^a   Witter, Richard L ^b   Pandiri, Arun R ^a,c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

Author keywords

control; Marek's disease; revaccination; vaccine

Indexed keywords

MAREK DISEASE VACCINE; VIRUS DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHICK EMBRYO; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; GERMFREE ANIMAL; IMMUNIZATION; IMMUNOLOGY; MARDIVIRUS; MAREK DISEASE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TIME; VACCINATION;

ANIMALS; CHICK EMBRYO; CHICKENS; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; IMMUNIZATION, SECONDARY; MARDIVIRUS; MAREK DISEASE; MAREK DISEASE VACCINES; REAL-TIME POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES; TIME FACTORS; VACCINATION;

GALLID HERPESVIRUS 2; MELEAGRID HERPESVIRUS 1;

EID: 84858192281     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9930-091311-Reg.1     Document Type: Article

References (54)

1. Baigent, S. J., L. J. Petherbridge, L. P. Smith, Y. Zhao, P. M. Chesters, and V. K. Nair. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J. Gen. Virol. 87:769-776. 2006.
2. Baigent, S. J., L. P. Smith, R. J. Currie, and V. K. Nair. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathol. 36:467-474. 2007.
3. Ball, R. F., and J. Lyman. Revaccination of chicks for Marek's disease at twenty-one days old. Avian Dis. 21:440-444. 1977.
4. Benda, V., and I. Holzanek. Effect of large doses of turkey herpes virus on antibody response in chickens. Folia Biol. 21:184-188. 1975.
5. Chen, C. L. H., L. L. Ager, G. L. Gartland, and M. D. Cooper. Identification of a T3/T cell receptor complex in chicken. J. Exp. Med. 164:375-380. 1986.
6. Cho, B. R., R. K. Balch, and R. W. Hill. Marek's disease vaccine breaks: differences in viremia of vaccinated chickens between those with and without Marek's disease. Avian Dis. 20:496-503. 1976.
7. Churchill, A. E., L. N. Payne, and R. C. Chubb. Immunization againstMarek's disease using a live attenuated virus. Nature 221:744-747. 1969.
8. Cortes, A. L., E. R. Montiel, and I. M. Gimeno. Validation of Marek's disease diagnosis and monitoring of Marek's disease vaccines from samples collected in FTA cards. Avian Dis. 53:510-516. 2009.
9. Cortes, A. L., E. R. Montiel, S. Lemiere, and I. M. Gimeno. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time PCR. Avian Dis. 55:302-310. 2011.
10. Cronenberg, A. M., C. E. H. Van Geffen, J. Dorrestein, A. N. Vermeulen, and P. J. A. Sondermeijer. Vaccination of broilers with HVT expressing an Eimeria acervulina antigen improves performance after challenge with Eimeria. Acta Virol. 43:192-197. 1999.
11. Cui, X., L. F. Lee, H. D. Hunt, W. M. Reed, B. Lupiani, and S. M. Reddy. A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain. Avian Dis. 49:199-206. 2005.
12. Darteil, R., M. Bublot, E. Laplace, J. F. Bouquet, J. C. Audonnet, and M. Riviere. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211:481-490. 1995.
13. Dunn, J. R., R. L. Witter, R. F. Silva, L. F. Lee, J. Finlay, B. A. Marker, J. B. Kaneene, R. M. Fulton, and S. D. Fitzgerald. The effect of the time interval between exposures on the susceptibility of chickens to superinfection with Marek's disease virus. Avian Dis. 54:1038-1049. 2010.
14. Eleazer, T. H. Marek's revaccination has no advantage. Poult. Dig. 37:154. 1978.
15. Ewert, D. L., M. S. Munchus, C. L. Chen, and M. D. Cooper. Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants. J. Immunol. 132:2524-2530. 1984.
16. Gimeno, I. M. Future strategies for controlling Marek's disease. In: Marek's disease. V. Nair and F. Davison, eds. Elsevier, Oxford, United Kingdom. pp. 186-198. 2004.
17. Gimeno, I. M., A. L. Cortes, and R. F. Silva. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Dis. 52:203-208. 2008.
18. Gimeno, I. M., R. L. Witter, A. M. Fadly, and R. F. Silva. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. Avian Pathol. 34:332-340. 2005.
19. Gimeno, I. M., R. L. Witter, H. D. Hunt, S. M. Reddy, and W. M. Reed. Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathol. 33:59-68. 2004.
20. Gimeno, I. M., R. L. Witter, and W. M. Reed. Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype. Avian Dis. 43:721-737. 1999.
21. Gimeno, I. M., R. L. Witter, A. L. Cortes, S. M. Reddy, and A. R. Pandiri. Standardization of a model to study revaccination against Marek's disease under laboratory conditions. Avian Pathol 41:59-68. 2012.
22. Heckert, R. A., J. Riva, S. Cook, J. K. McMillen, and R. D. Schwartz. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis. 40:770-777. 1996.
23. Hunt, H. D., B. Lupiani, M. M. Miller, I. M. Gimeno, L. F. Lee, and M. S. Parcells. Marek's disease virus down regulates surface expression of MHV (B complex) class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology 282:198-205. 2001.
24. Ianconescu, M., H. G. Purchase, and B. R. Burmester. Influence of natural exposure on response to subsequent challenge with virulent Marek's disease virus. Avian Dis. 15:745-752. 1971.
25. Islam, A. F., B. Harrison, B. F. Cheetham, T. J. Mahony, P. L. Young, and S. W. Walkden-Brown. Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction. J. Virol. Methods 119:103-113. 2004.
26. Kano, R., S. Konnai, M. Onuma, and K. Ohashi. Cytokine profiles in chickens infected with virulent and avirulent Marek's disease viruses: interferon-gamma is a key factor in the protection of Marek's disease by vaccination. Microbiol. Immunol. 53:224-232. 2009.
27. Kross, I. Isolation of highly lytic serotype 1 Marek's disease viruses from recent field outbreaks in Europe. In: Current research on marek's disease. R. F. silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 113-118. 1996.
28. Lee, L. F., K. S. Kreager, J. Arango, A. Paraguassu, B. Beckman, H. Zhang, A. Fadly, B. Lupiani, and S. M. Reddy. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens. Vaccine 28:1294-1299. 2010.
29. Lee, L. F., and R. L. Witter. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine. Avian Dis. 35:452-459. 1991.
30. Lee, L. F., R. L. Witter, S. M. Reddy, P. Wu, N. Yanagida, and S. Yoshida. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus. Avian Dis. 47:549-558. 2003.
31. Morgan, R. W., J. Gelb Jr., C. S. Schreurs, D. Lutticken, J. K. Rosenberger, and P. J. A. Sondermeijer. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 36:858-870. 1992.
32. Nazerian, K., L. F. Lee, N. Yanagida, and R. Ogawa. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66:1409-1413. 1992.
33. Nazerian, K., R. L. Witter, L. F. Lee, and N. Yanagida. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:368-376. 1996.
34. Paramithiotis, E., L. Tkalec, and M. J. H. Ratcliffe. High levels of CD45 are coordinately expressed with CD4 and CD8 on avian thymocytes. J. Immunol. 147:3710-3717. 1991.
35. Petherbridge, L., K. Howes, S. J. Baigent, S. Evans, N. Osterrieder, and K. Venugopal. Infectious bacterial artificial chromosome of Marek's disease virus vaccine strain CVI988: a novel approach for generation of molecularly defined vaccines. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology, Newark, DE. p. 47. 2002.
36. Riddell, C., B. S. Milne, and P. M. Biggs. Herpes virus of turkey vaccine: viraemias in field flocks and in experimental chickens. Vet. Rec. 102:123-125. 1978.
37. Rispens, B. H., J. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125. 1972.
38. Schat, K. A., and B. W. Calnek. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082. 1978.
39. Schat, K. A., A. R. Omar, L. F. Lee, and H. D. Hunt. Induction of glycoprotein B (gB)-specific cytotoxic T cells after vaccination with recombinant fowl poxvirus expressing gB. In: Current research on Marek's disease. R. F. Silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 432-435. 1996.
40. Sharma, J. M., and B. R. Burmester. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149. 1982.
41. Sharma, J. M., L. F. Lee, and P. S. Wakenell. Comparative viral, immunologic and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am. J. Vet. Res. 45:1619-1623. 1984.
42. Silva, R. F., I. M. Gimeno, A. E. El-Gohari, L. F. Lee, and J. Dunn. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses. Avian Di.s. 2011.
43. Spencer, J. L., A. A. Grunder, A. Robertson, and G. W. Speckmann. Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance. Avian Dis. 16:94-107. 1972.
44. Tischer, B. K., D. Schumacher, M. Beer, J. Beyer, J. P. Teifke, K. Osterrieder, V. Zelnik, F. Fehler, and N. Osterrieder. Efficacy of a BAC DNA vaccine against Marek's disease. Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology, Newark, DE. p. 46. 2002.
45. Venugopal, K., A. P. Bland, L. J. N. Ross, and L. N. Payne. Pathogenicity of an unusual highly virulent Marek's disease virus isolated in the United Kingdom. In: Current research on Marek's disease. R. F. Silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 119-124. 1996.
46. Witter, R. L. Increased virulence of marek's disease virus field isolates. Avian Dis. 41:149-163. 1997.
47. Witter, R. L. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses. Avian Dis. 46:925-937. 2002.
48. Witter, R. L., and I. M. Gimeno. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek's disease virus. Avian Dis. 50:354-365. 2006.
49. Witter, R. L., I. M. Gimeno, W. M. Reed, and L. D. Bacon. An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus. Avian Dis. 43:704-720. 1999.
50. Witter, R. L., and K. S. Kreager. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Dis. 48:768-782. 2004.
51. Witter, R. L., D. Li, D. Jones, L. F. Lee, and H. J. Kung. Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Dis. 41:407-421. 1997.
52. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538. 1970.
53. Wu, C., J. Gan, Q. Jin, C. Chen, P. Liang, Y. Wu, X. Liu, L. Ma, and F. Davison. Revaccination with Marek's disease vaccines induces productive infection and superior immunity. Clin. Vaccine Immunol. 16:184-193. 2009.
54. Zanella, A., J. Valantines, G. Granelli, and G. Castell. Influence of strain of chickens on the immune response to vaccination against Marek's disease. Avian Pathol. 4:247-253. 1975.